Skip to main content
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
100.99
-1.90 (-1.85%)
Jun 20, 2025, 1:03 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
Novel Therapies for the Management of Central Nervous System Disorders
385.69M
Log In
Log In
Novel Therapies for the Management of Central Nervous System Disorders Growth
42.53%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
United States
378.16M
Log In
Log In
United States Growth
91.74%
Log In
Log In
Non-United States
7.53M
Log In
Log In
Non-United States Growth
-89.73%
Log In
Log In